Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Clinical utilization of whole-body PET/MRI in childhood sarcoma. Pediatr Radiol 2021 Mar;51(3):471-479

Date

10/12/2020

Pubmed ID

33040234

DOI

10.1007/s00247-020-04834-7

Scopus ID

2-s2.0-85092394975 (requires institutional sign-in at Scopus site)   3 Citations

Abstract

Hybrid positron emission tomography (PET)/magnetic resonance imaging (MRI) has emerged as a useful tool that combines the superior tissue contrast of MRI with the targeted functional imaging of PET. In the assessment of sarcomas in children, PET/MRI has the potential to serve as a single point of service, allowing superior anatomical imaging and evaluation of metabolic uptake during one imaging session. In this pictorial essay, we review our preliminary experience with PET/MRI in the evaluation of pediatric sarcoma. The limitations and contraindications of PET/MRI are also discussed.

Author List

Qi J, Thakrar PD, Browning MB, Vo N, Kumbhar SS

Authors

Jing Qi MD, PhD Associate Professor in the Radiology department at Medical College of Wisconsin
Pooja Thakrar MD Associate Professor in the Radiology department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Child
Fluorodeoxyglucose F18
Humans
Magnetic Resonance Imaging
Positron-Emission Tomography
Radiopharmaceuticals
Sarcoma
Soft Tissue Neoplasms